0000874015-19-000097.txt : 20190703 0000874015-19-000097.hdr.sgml : 20190703 20190703183947 ACCESSION NUMBER: 0000874015-19-000097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190701 FILED AS OF DATE: 20190703 DATE AS OF CHANGE: 20190703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOSCALZO JOSEPH CENTRAL INDEX KEY: 0001276128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 19942904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-07-01 0000874015 IONIS PHARMACEUTICALS INC IONS 0001276128 LOSCALZO JOSEPH C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Common Stock 2019-07-01 2019-07-01 4 M 0 666 0 A 11085 D Common Stock 2019-07-01 2019-07-01 4 M 0 667 0 A 11752 D Common Stock 2019-07-02 2019-07-02 4 M 0 889 0 A 12641 D Common Stock 2019-07-03 2019-07-03 4 M 0 667 0 A 13308 D Restricted Stock Units 2019-07-01 2019-07-01 4 M 0 666 0 D Common Stock 666 0 D Restricted Stock Units 2019-07-01 2019-07-01 4 M 0 667 0 D Common Stock 667 666 D Restricted Stock Units 2019-07-02 2019-07-02 4 M 0 889 0 D Common Stock 889 2666 D Restricted Stock Units 2019-07-03 2019-07-03 4 M 0 667 0 D Common Stock 667 1333 D Restricted Stock Units 2019-07-01 2019-07-01 4 A 0 7110 0 A Common Stock 7110 7110 D Director Stock Option (right to buy) 64.80 2019-07-01 2019-07-01 4 A 0 16000 0 A 2020-07-01 2029-06-30 Common Stock 16000 16000 D Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019. Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019. /s/Patrick R. O'Neil, attorney-in-fact 2019-07-03